What is the primary purpose of these tender offers announced by Anthem?

The primary purpose of these tender offers is for Anthem, Inc. (now Elevance Health) to manage its outstanding debt obligations. This includes potentially refinancing debt that is maturing soon (the 2019 notes) and managing its overall debt structure and cost by repurchasing other outstanding notes.

What specific debt instruments are being targeted in these tender offers?

The tender offers targeted two main groups: (i) any and all of the company's outstanding 7.000% Notes due 2019, and (ii) an aggregate principal amount of up to $600 million (subject to increase) of its outstanding 6.375% Notes due 2037, 5.950% Notes due 2034, 5.850% Notes due 2036, 5.800% Notes due 2040, and 5.100% Notes due 2044.

What does 'any and all' offer mean in the context of the 2019 notes?

An 'any and all' offer means that the company is willing to purchase all of the specified notes (in this case, the 7.000% Notes due 2019) that bondholders choose to tender, regardless of the total amount tendered, up to the offer's expiration. This is often done for notes that are nearing maturity or when the issuer wants to eliminate that specific debt obligation entirely.

What is the significance of the different expiration dates for the tender offers?

The different expiration dates, with the 'any and all' offer for the 2019 notes expiring earlier (November 20, 2017) than the 'maximum tender offer' (December 12, 2017), allow the company to manage the timing of its cash outflows and potentially prioritize which debt it wants to retire first. It also provides holders of different note series with distinct windows to participate.

ELV 8-K SEC Disclosure — Nov 14, 2017

Summary

Elevance Health, Inc. (then operating as Anthem, Inc.) filed an 8-K on November 14, 2017, to announce the commencement of cash tender offers for its outstanding debt. This action indicates the company's proactive management of its debt obligations and capital structure. The tender offers included an "any and all" offer for its 7.000% Notes due 2019 and a "maximum tender offer" for several other note series, with an aggregate principal amount up to $600 million, subject to increase. These strategic moves are often undertaken to optimize interest expenses, extend debt maturities, or adjust leverage ratios in anticipation of future financial needs or market conditions. Investors should note the specific dates and terms associated with these tender offers, as they represent a significant event related to the company's financial liabilities. The "any and all" offer for the 2019 notes and the larger tender for longer-dated notes suggest a focus on potentially refinancing upcoming maturities and managing the cost of its long-term debt. The full details and implications would be elaborated in the accompanying offer to purchase document, which is referenced in the filing. This proactive debt management can be a positive signal regarding the company's financial health and its commitment to efficient capital allocation.

Key Highlights

1Anthem, Inc. (now Elevance Health) launched cash tender offers for outstanding debt on November 14, 2017.
2The company is making an 'any and all' offer for its 7.000% Notes due 2019.
3A separate 'maximum tender offer' is being conducted for up to $600 million (subject to increase) of other note series with maturities ranging from 2034 to 2044.
4The tender offers aim to manage the company's debt structure and potentially refinance existing obligations.
5The 'any and all' offer for the 2019 notes had an early expiration date of November 20, 2017.
6The 'maximum tender offer' had a later expiration date of December 12, 2017.
7The details of the tender offers are outlined in a press release filed as an exhibit to the 8-K.

Elevance Health, Inc. 8-K Report, Corporate Update (Nov 14, 2017)

Summary

Key Highlights

Frequently Asked Questions